LENVIMA 4 mg hard capsules, E7386, KEYTRUDA 25 mg/mL concentrate for solution for infusion, E7386, LENVIMA 10 mg hard capsules
E7386-G000-201
Phase 2 small_molecule active
Quick answer
LENVIMA 4 mg hard capsules, E7386, KEYTRUDA 25 mg/mL concentrate for solution for infusion, E7386, LENVIMA 10 mg hard capsules for colorectal cancer, melanoma, hepatocellular carcinoma is a Phase 2 program (small_molecule) at Eisai GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eisai GmbH
- Indication
- colorectal cancer, melanoma, hepatocellular carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active